Echinococcus multilocularis infection in mice: In vivo treatment with a low dose of IFN-γ decreases metacestode growth and liver fibrogenesis

Parasite

Volumn 5, Issue 3, 1998, Pages 231-237

  Liance, M ^a   Ricard Blum, S ^b   Emery, I ^a   Houin, R ^a   Vuitton, D A ^c  

^a FACULTÉ DE MÉDECINE   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

Echinococcus multilocularis; IFN ; Liver fibrosis; Pyridinolines

Indexed keywords

ECHINOCOCCUS MULTILOCULARIS; MURINAE;

AMINO ACID; HELMINTH ANTIBODY; IMMUNOGLOBULIN G; PYRIDINOLINE; RECOMBINANT GAMMA INTERFERON;

AKR MOUSE; ANIMAL; ARTICLE; BIOSYNTHESIS; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DOSE RESPONSE; ECHINOCOCCUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; LIVER HYDATID CYST; MOUSE; ORGAN SIZE; PARASITOLOGY; PATHOLOGY; URINE;

AMINO ACIDS; ANIMALS; ANTIBODIES, HELMINTH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHINOCOCCOSIS, HEPATIC; ECHINOCOCCUS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; INTERFERON-GAMMA, RECOMBINANT; LIVER; MICE; MICE, INBRED AKR; ORGAN SIZE;

EID: 0032158603     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/1998053231     Document Type: Article

References (30)

1. ALI-KHAN Z. Echinococcus multilocularis: cell-mediated immune response in early and chronic alveolar echinococcosis. Experimental Parasitology, 1978, 46, 157-165.
2. BANCHEREAU J. & WIDJENES J. The multiple activities of interferon gamma. In: Marker Proteins in Inflammation, Walter de Gruyter & Co, Berlin, 1986, 3, 551-569.
3. CZAJA M.J., WEINER F.R., TAKAHASHI S., GIAMBRONE M.A., VAN DER MEIDE P.H., SCHELLEKENS H., BIEMPICA L. AND ZERN M.A. γ-Interferon inhibits collagen deposition in murine schistosomiasis. Hepatology, 1989, 10, 795-800.
4. DAVIS G.L., BALART L.A., SCHIFF E.R., LINDSAY K., BODENHEIMER H.C., PERILLO R.P., CAREY W., JACOBSON I.M., PAYN J., DIENSTAG J.L., VANTHIEL D.H., TAMBURRO C., LEFKOWITCH J., ALBRECHT J., MESCHIEVITZ C., ORTEGO T.J., GIBAS A., and the Hepatitis Interventional Therapy group. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. The New England Journal of Medicine, 1989, 321, 1501-1506.
5. EMERY I., LIANCE M. & LECLERC C. Secondary Echinococcus multilocularis infection in A/J mice: delayed metacestode development is associated with Th1 cytokine production. Parasite Immunology, 1997, 19, 493-503.
6. EMERY I., LIANCE M., DERIAUD E., VUITTON D.A., HOUIN R. & LECLERC C. Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunology, 1996, 18, 463-472.
7. GOMEZ B., ARDAKANI S., EVANS B.J., MERRELL L.D., JENKINS D.K. & KUNG V.T. Monoclonal antibody assay for free urinary pyridinium cross-links. Clinical Chemistry, 1996, 42, 1168-1175.
8. GOTTSTEIN B., WUNDERLIN E. & TANNER I. Echinococcus multilocularis : parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57BL/6J) or « resistant » (C57BL/10) to secondary alveolar echinococcosis. Clinical and Experimental Immunology, 1994, 96, 245-252.
9. GRENARD P., BLANQUIER B. & RICARD-BLUM S. The urinary excretion of the collagen cross-link pyridinoline increases during liver fibrosis. Journal of Hepatology, 1997, 26, 1356-1362.
10. JENNE L., KILWINSKI J., RADLOFF P., FLICK W. & KERN P. Clinical efficacy and immunological alterations of IFN-g therapy in alveolar echinococcosis. Clinical Infectious Diseases, 1998, in press.
11. JIMENEZ S.A., FREUNDLICH B. & ROSENBLOOM. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. Journal of Clinical Investigation, 1984, 74, 1112-1116.
12. LIANCE M., BRESSON-HADNI S., MEYER J.P., HOUIN R. & VUITTON D. Cellular immunity in experimental Echinococcus multilocularis infection. I - Sequential and comparative study of specific in vivo delayed-type hypersensitivity against E. multilocularis antigens in resistant and sensitive mice. Clinical and Experimental Immunology, 1990, 82, 373-377.
13. MALLAT A., PREAUX A.M., BLAZEJEWSKI S., ROSEMBAUM J., DHUMEAUX D. & MAVIER P. Interferon alpha and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology, 1995, 21, 1003-1010.
14. MIGUET J.P., BRESSON-HADNI S. & VUITTON D. Echinococcosis of the liver, in: Oxford Textbook of clinical Hepatology. McIntyre N., Bebhamou J-P, Bircher J., Rizzetto M. & Rodes J. (eds), Oxford University Press, 1991, 721-730.
15. MURRAY H.W. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Annals of Internal Medicine, 1988, 108, 595-608.
16. PLAYFORD M.C., OOI H-K., OKU Y. & KAMIYA M. Secondary Echinococcus multilocularis infection in severe combined immunodeficient (SCID) mice: biphasic growth of the larval cyst mass. International Journal for Parasitology, 1992, 22, 975-982.
17. RAU M.E. & TANNER C.E. BCG suppresses growth and metastasis of hydatic infection. Nature, 1975, 256, 318-319.
18. REISER K., MCCORMICK R.J. & RUCKER R.B. Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB Journal, 1992, 6, 2439-2449.
19. REUBEN J.M. & TANNER C.E. Protection against experimental echinococcosis by non-specifically stimulated peritoneal cells. Parasite Immunology, 1983, 5, 61-66.
20. RICARD-BLUM S., BRESSON-HADNI S, VUITTON D.A., VILLE G. & GRIMAUD J.A. Hydroxypyridinium collagen cross-links in human liver fibrosis: study of alveolar echinococcosis. Hepatology, 1992a, 15, 599-602.
21. RICARD-BLUM S., BRESSON-HADNI S., GUERRET S., GRENARD P., VOLLE P.J., RISTELI L., GRIMAUD J.A. & VUITTON D.A. Mechanisms of collagen network stabilization in human irreversible granulomatous liver fibrosis. Gastroenterology, 1996, 111, 172-182.
22. RICARD-BLUM S., GRENARD P., BRESSON-HADNI S., GUERRET S., CHOSSEGROS P., CHEVALLIER M., RISTELI L. & VUITTON D. Investigation of collagen cross-linking at the urinary and tissue levels in human liver fibrosis. In: Cells of the Hepatic Sinusoid, Wisse E., Knook D.L. & Balabaud C. (eds), Kupffer Cell Foundation, Leiden, The Netherlands, 1997, 6, 62-63.
23. RICARD-BLUM S , LIANCE M., HOUIN R., GRIMAUD J.A. & VUITTON D.A. Covalent linking of liver collagen by pyridinoline increases in the course of experimental alveolar echinococcosis. Parasite, 1995, 2, 113-118.
24. RICARD-BLUM S., VILLE G. & GRIMAUD J.A. Pyridinoline, a mature collagen cross-link, in fibrotic livers from Schistosoma mansoni-infected mice. American Journal of Tropical Medicine and Hygiene, 1992b, 47, 816-820.
25. SCHMID M., SAMONIGG H., STÖGER H., AUER H., STERNTHAL M.H., WILDERS-TRUSCHNIG M. & REISINGER E.C. Use of interferon g and mebendazole to stop the progression of alveolar hydatid disease: case report. Clinical Infectious Diseases, 1995, 20, 1543-1546.
26. SUZUKI Y., CONLEY F.K. & REMINGTON J.S. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infection and Immunity, 1990, 58, 3050-3055.
27. VATER C.A., HARRIS E.D. & SIEGEL R.C. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochemical Journal, 1979, 181, 639-645.
28. VUITTON D.A., TRAN V.P., GUERRET-STOCKER S., GRIMAUD J.A., LIANCE M. & HOUIN R. Development of fibrosis in hepatic alveolar echinococcosis: a sequential study in mice infected with Echinococcus multilocularis. In: Marker Proteins in Inflammation, Bienvenu J., Grimaud J.A., Laurent P. (eds), Walter de Gruyter, Berlin, 1986, 491-500.
29. WATIER H., PANCRE V., LANDAU D., CAPRON A. & AURIAULT C. IFN-g treatment of rodents infected with erythrocytic stages of Plasmodium chabaudi: differential effects according to the immunological status. International Journal for Immunopharmacology, 1993, 15, 293-299.
30. WEN H., PEI-FAN Z., WEN-GUANG Y., JIAN L., YUN-HAI W., JING-HUI Z. & NEW R.R.C. Albendazole chemotherapy for human cystic and alveolar echinococcosis in north-western China. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1994, 88, 340-343.